Keyword: Stanford University
The week’s biotech news included a map of the human lung that could aid asthma drug development and a compound that thwarts rhinoviruses like colds.
The series A round sets Confo up to advance drugs derived from a novel way of stabilizing GPCRs and performing more sensitive screens.
Inhibiting CD22 may help treat or prevent neurodegenerative diseases by restoring the brain's microglia, a Stanford team found.
Canvassing more than 400,000 people in 8 months, Apple has finished an investigation of its smartwatch’s ability to detect irregular heart rhythms.
A Stanford-led team identified a protein that helps small arteries grow, thereby healing oxygen-starved, damaged heart tissues in mice.
A team of Stanford University scientists has found a way to direct a regenerative diabetes medicine to the right cells more precisely.
Three patients with quadriplegia used a brain-computer interface to control a commercial tablet just by thinking about moving and clicking a cursor.
CuraSen Therapeutics has pulled off a $54.5 million series A funding round as it gains big-name backing to help tackle neurodegenerative disorders.
CRISPR-GO allows scientists to reorganize the genome—taking specific pieces and placing them at new locations in a cell’s nucleus.
A newly found stem cell can differentiate into just bone cells without the unwanted lineages found in previous cultures.